Allergan, Inc. v. Watson Laboratories, Inc. -Florida

NOTE: ThiS order is nonprecedential United States Court of AppeaIs for the FederaI Circuit ALLERGAN, INC., ALLERGAN USA, INC., ALLERGAN SALES, LLC, ENDO PHARMACEUTICALS SOLUTIONS, INC., AND SUPERNUS PHARMACEUTICALS, INC., Plaintiffs-Appellan,ts, V. WATSON LABORATORIES, INC. - FLORIDA, Defendcmt~Appellee, AND SANDOZ, INC., Defen,dant-Appellee, AND PADDOCK LABORATORIES, INC., Defen,dan,t-Appellee. 2012-1310 Appea1 from the United States District C0urt for the District of DelaWare in consolidated case n0. 09-CV-0511, Chief Judge Greg0ry M. S1eet. ON MOTION ALLERGAN V. WATSON LABS 2 ORDER Upon consideration of the April 27, 2012 order expe- diting briefing on the merits of this appea1, IT ls OR1)ERED THAT: (1) Oral argument for the merits of the appeal is scheduled to be held at 10 a.m., June 14, 2012, in Court- room 402. The parties shall notify the clerk in writing of the name of the counsel who will present oral argument no later than May 25, 2012. 4 (2) A copy of this order shall be transmitted to the merits panel assigned to hear this case. FOR THE COURT MA¥ 02 2012 /s/ J an Horba1y Date J an Horbaly Clerk cc: Jonathan E. Singer, Esq. Charles A. Weiss, Esq. Deanne E. Maynard, Esq. mfg W@11dY M- Ward, Es . .s.c0unT0FAPPsALsFon q U mEFEnEa.v_iclncu1T 38 mw 02 2012 .\mHoaaiiv eisen